Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masafumi Inokuchi

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker]Hirofumi Terakawa, Katsunobu Oyama, Toshifumi Watanabe, et al.
Molecular and Clinical Oncology|March 21, 2014
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancerHidehiro Tajima, Hirohisa Kitagawa, Tomoya Tsukada, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.
Molecular and Clinical Oncology|May 23, 2017
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancerHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.
Oncology Letters|July 12, 2012
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44Hidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.
Oncology Letters|October 19, 2013
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell lineAtsushi Hirose, Hidehiro Tajima, Tetsuo Ohta, et al.
Oncology Reports|July 7, 2012
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancerKatsuhiro Yoshimoto, Hidehiro Tajima, Tetsuo Ohta, et al.
Molecular Medicine Reports|June 12, 2013
Concentration of tissue angiotensin II increases with severity of experimental pancreatitisHiroyuki Furukawa, Atsushi Shinmura, Hidehiro Tajima, et al.
Journal of Gastroenterology|February 22, 2014
Evaluation of serum HER2-ECD levels in patients with gastric cancerKatsunobu Oyama, Sachio Fushida, Tomoya Tsukada, et al.
Oncology Letters|December 11, 2012
Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case reportHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 19, 2014
[A case of advanced gastric cancer in which the serum HER2-ECD level could be used as a biomarker]Hirofumi Terakawa, Katsunobu Oyama, Toshifumi Watanabe, et al.
Molecular and Clinical Oncology|March 21, 2014
A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancerHidehiro Tajima, Hirohisa Kitagawa, Tomoya Tsukada, et al.
Experimental and Therapeutic Medicine|September 13, 2012
Pilot study of neoadjuvant chemotherapy with gemcitabine and oral S-1 for resectable pancreatic cancerHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.
Molecular and Clinical Oncology|May 23, 2017
Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancerHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.
Oncology Letters|July 12, 2012
Neoadjuvant chemotherapy with gemcitabine for pancreatic cancer increases in situ expression of the apoptosis marker M30 and stem cell marker CD44Hidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.
Oncology Letters|October 19, 2013
Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell lineAtsushi Hirose, Hidehiro Tajima, Tetsuo Ohta, et al.
Oncology Reports|July 7, 2012
Increased E-selectin in hepatic ischemia-reperfusion injury mediates liver metastasis of pancreatic cancerKatsuhiro Yoshimoto, Hidehiro Tajima, Tetsuo Ohta, et al.
Molecular Medicine Reports|June 12, 2013
Concentration of tissue angiotensin II increases with severity of experimental pancreatitisHiroyuki Furukawa, Atsushi Shinmura, Hidehiro Tajima, et al.
Journal of Gastroenterology|February 22, 2014
Evaluation of serum HER2-ECD levels in patients with gastric cancerKatsunobu Oyama, Sachio Fushida, Tomoya Tsukada, et al.
Oncology Letters|December 11, 2012
Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case reportHidehiro Tajima, Tetsuo Ohta, Hiroyuki Shinbashi, et al.
Pageof 9